Science and health experts are bullish on the news about the Pfizer and BioNTech coronavirus vaccine candidate.
The main reason for the excitement is the vaccine looks like it's on pace to fly right past the Food and Drug Administration's 50 percent efficacy threshold, according to its interim analysis, which pegged the rate at 90 percent so far. There's more good news between the lines, though — the companies say they haven't observed any safety concerns among trial volunteers, the immune response should last for up to a year, and it's unlikely any mutations would be able to overcome the immune response.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Today's political cartoons - February 23, 2025Cartoons Saturday's cartoons - loser's game, unexpected consequences, and more
-
5 slow on the draw cartoons about Democrats' response to TrumpCartoons Artists take on taking a stand, staying still as a statue, and more
-
A road trip through ZimbabweThe Week Recommends The country is 'friendly and relaxed', with plenty to see for those who wish to explore
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
-
Bird flu one mutuation from human threat, study findsSpeed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
-
Dark chocolate tied to lower diabetes riskSpeed Read The findings were based on the diets of about 192,000 US adults over 34 years
